PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
01-Feb-2023 Formycon AG upsizes capital increase from authorized capital following strong demand Formycon AG
01-Feb-2023 Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market B3C newswire
01-Feb-2023 Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab) Formycon AG
01-Feb-2023 Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth Formycon AG
01-Feb-2023 BioAscent reports major revenue growth in 2022 BioAscent
01-Feb-2023 PureTech to Present at the SVB Securities Global Biopharma Conference PureTech Health plc
01-Feb-2023 BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes(TM) for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients BioCardia
01-Feb-2023 ABPI response to new MHRA fees announced for 1 April 2023 ABPI
01-Feb-2023 Pharmapack Drug Delivery Index hits record high Pharmapack
01-Feb-2023 Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia Ellipses Pharma
01-Feb-2023 Neuraxpharm announces closing of acquisition of established products from Sanofi Neuraxpharm
01-Feb-2023 Sequana Medical announces grant of additional DSR® patent in United States Sequana Medical
01-Feb-2023 Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™ Terebellum
01-Feb-2023 Aptamer Group partner with BaseCure Therapeutics to develop new targeted gene therapies Aptamer Group
01-Feb-2023 X-Chem and Kymera Expand Existing Partnership X-Chem
01-Feb-2023 Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board B3C newswire
01-Feb-2023 CureVac Welcomes Myriam Mendila as New Chief Development Officer CureVac
01-Feb-2023 Lausanne University Hospital Investigates Use of PENTIXAFOR in Cardio-Vascular Setting Eckert & Ziegler Strahlen- und Medizintechnik AG
01-Feb-2023 Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer Adrenomed AG
31-Jan-2023 CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis® CureVac